James advises a range of clients on technologies across the life sciences, with a focus on biological therapeutic products, such as nucleic acids and antibodies, and computational biology, but extending to areas as broad as medical devices and bio-materials. He is experienced in European patent prosecution and drafting, and also enjoys providing advice on matters such as patentability and patent infringement, as well as carrying out contentious work such as third-party observations.
James has particular technical expertise in cross-sector subject-matter, with a background including research projects on deep-learning AI models for object tracking, as well as molecular dynamics simulations, ligand pocket prediction and protein docking. He finds this expertise particularly useful when advising clients on navigating the complexities of patent law for cross-sector innovation in bioinformatics and digital health.
James graduated from Imperial College London in 2020 with a bachelor’s degree in Biotechnology and went on to achieve a distinction in MSc Applied Biosciences and Biotechnology during the following year. He joined Kilburn & Strode as a trainee patent attorney in our Life Sciences and Chemistry team in 2021.